Skip to content

CLDX - Celldex Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchC

Celldex Therapeutics Inc

CLDX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

C

CLDXCelldex Therapeutics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $45.14
52-wk low: $21.34
Prev close: $32.85
Mkt cap: $3.27B
Beta: 0.84
P/S: 20725.8x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$647.4M

MI
Millennium
Israel Englander · Q2 2026 13F
$43.6M
position
TS
Two Sigma
Q2 2026 13F

Earnings

Reported Aug 6, 2026

Earnings came in 9.6% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $3.3B

Valuation

P/S20725.83
P/B4.59

Quality

Operating margin-366468.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: CLDX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $3.27B
Beta: 0.84

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

4.6x

Profit margin

+0.0%

Op margin

-366468.0%

ROE

-43.9%

$24.6M

position

CI

Citadel

Ken Griffin · Q1 2026 13F

$6.4M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for CLDX

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.94+9.6%

-$1.04 expected

Next report

What the street expects next

EPS expected

-$1.01

-$1.05 to -$0.94

Revenue expected

$922.4K

8 analysts

Last 30 days

4up1down

Analysts raising estimates

Estimate drift

+0.07

Change in 30 days

-43.9%

ROA-27.6%

Growth

Beta0.84